Trevor James
The hepatitis B vaccine is generally administered as a three-dose series, with shots given at 0, 1, and 6 months. However, the schedule may vary depending on the vaccine brand and country-specific guidelines. The first dose is typically given within 24 hours of birth or within 12 hours if the mother is hepatitis B positive, followed by two additional doses according to the recommended schedule. In some cases, a two-dose vaccine series, such as Heplisav-B, may be recommended for adults aged 18 and older. The hepatitis B vaccine is safe and effective in providing long-term protection against acute and chronic hepatitis B infections, which can lead to liver disease and cancer.
| Characteristics | Values |
|---|---|
| Number of doses | 2 or 3 (depending on brand) |
| Dosage schedule | First dose: within 24 hours of birth or in the delivery room. Second dose: at least one month after the first dose. Third dose: at least 4 months after the first dose and 2 months after the second dose. |
| Administration | Injection or shot, generally given in the arm |
| Protection | Long-term protection against hepatitis B, hepatitis delta, and liver cancer |
| Risk factors | Infants born to mothers with hepatitis B, sexually active people, people with diabetes, international travellers to countries with high or intermediate levels of hepatitis B, etc. |
| Vaccine brands | Engerix-B, Twinrix, Heplisav-B, PreHevbrio, Recombivax HB |
Explore related products
What You'll Learn
Hepatitis B vaccine schedules
The Hepatitis B vaccine is generally given as an injection in the arm and is available at doctors' offices, local health departments, and clinics. The vaccine is typically administered as a three-dose series, with the second dose administered at least one month after the first, and the third and final dose administered at least four months after the first dose and two months after the second. This schedule is recommended for both children and adults.
For newborns, the first dose of the hepatitis B vaccine should be given within 12 to 24 hours of birth, followed by the remaining two doses according to the standard schedule. This is critical to eliminating hepatitis B and protecting babies from lifelong infection. The World Health Organization (WHO) and the Advisory Committee on Immunization Practices (ACIP) recommend that all infants receive the hepatitis B vaccine at birth.
There are alternative vaccine schedules and brands available. For example, Engerix-B is a three-dose vaccine that can be administered in an accelerated four-dose schedule with a booster dose at one year. Twinrix is a four-dose vaccine that provides protection against both hepatitis A and B and is often chosen by those travelling outside the US on short notice. Heplisav-B is a two-dose vaccine approved for adults aged 18 and older in the US, with no booster dose required for long-term protection.
It is important to note that the hepatitis B vaccine can also be given as a stand-alone vaccine or as part of a combination vaccine, such as the pentavalent vaccine, which protects against five diseases. The vaccine brand, manufacturer, and schedule may vary depending on the country's national immunisation program and guidelines.
Flight Attendants and Vaccination: A Mandatory Requirement?
You may want to see also
Explore related products
Vaccine brands and types
The hepatitis B vaccine is available at doctors' offices, local health departments, and clinics. It is usually given as an injection into a muscle, in the arm for adults and children, and in the thigh for infants and children younger than one year. The hepatitis B vaccine is generally administered as a three-dose series, with the first dose recommended within 24 hours of birth. The remaining two to three doses are then given according to a schedule, typically at one month and four months after the first dose.
There are several vaccine brands and types available for hepatitis B. The World Health Organization (WHO) recommends a pentavalent vaccine that combines vaccines against diphtheria, tetanus, pertussis, and Haemophilus influenzae type B with the hepatitis B vaccine. This vaccine is approved in the US, but there is limited evidence on its effectiveness compared to individual vaccines.
Some of the hepatitis B vaccine brands approved by the US Food and Drug Administration (FDA) include:
- Engerix-B (GlaxoSmithKline): This is a three-dose vaccine that can be administered on an accelerated four-dose schedule, providing maximum long-term protection with a booster dose after one year.
- Recombivax HB: This vaccine is approved for people of all ages and can be used for adults when a previous vaccine manufacturer is unknown or unavailable.
- Heplisav-B (Dynavax): This is a two-dose vaccine approved for adults aged 18 and older, with no booster dose required after one year.
- Twinrix (GlaxoSmithKline): This four-dose vaccine provides protection against both hepatitis A and B and is a common choice for travellers outside the US.
- PreHevbrio: As of November 2024, the manufacturer has recalled this vaccine due to restructuring and discontinuing operations.
The hepatitis B vaccine is safe and effective, providing protection against hepatitis B, hepatitis delta, and reducing the risk of liver cancer. It is recommended for all newborns, infants, children, and adults at risk of infection.
Hepatitis B Vaccine: When and Why to Retake It
You may want to see also
Explore related products
$5 $32.99
Who should get the vaccine
The hepatitis B vaccine is generally recommended for all infants at birth and for children up to 18 years. The World Health Organization (WHO) recommends the hepatitis B vaccine for all newborns, and the vaccine is critical to eliminating hepatitis B. Babies born to infected mothers must receive the first dose of the hepatitis B vaccine in the delivery room or within the first 12 hours of life. For babies receiving the pentavalent vaccine, the first monovalent dose of the hepatitis B vaccine is given within 24 hours of birth, and the second and third doses of the HBV vaccine will be included in the first and second doses of the pentavalent vaccine.
The hepatitis B vaccine is also recommended for adults living with diabetes and those at high risk of infection due to their jobs, lifestyle, living situations, or country of birth. The Advisory Committee on Immunization Practices (ACIP) recommends hepatitis B vaccination for adults aged 19-59 and adults over 60 with risk factors for hepatitis B.
The hepatitis B vaccine is also recommended for international travellers to countries with high or intermediate levels of endemic hepatitis B virus infection. It is also a common choice of vaccine for those travelling at short notice outside the US.
Some other groups recommended to receive the hepatitis B vaccine include:
- People with end-stage renal disease, including pre-dialysis, haemodialysis, peritoneal dialysis, and home dialysis patients
- Residents and staff of facilities for people with developmental disabilities
- Sexually active persons who are not in a long-term, mutually monogamous relationship
Vaccines, Childhood Cancers, and the Truth
You may want to see also
Explore related products
Testing and interpreting results
Testing for hepatitis B status is critical, especially for pregnant women and babies. The hepatitis B vaccine is recommended for all newborns, and babies born to infected mothers must receive the first dose in the delivery room or within the first 12 hours of life. Testing is the only way to know if someone has a current infection or has recovered from a past infection.
The hepatitis B blood test, or "Hepatitis B Panel", requires just one blood sample and consists of three parts. All three test results are needed to fully understand a person's hepatitis B status. The three parts are:
- HBsAg (Hepatitis B surface antigen): A positive result indicates a person is infected with hepatitis B. This test detects the presence of the hepatitis B virus in the blood. If a person tests positive, further testing is needed to determine if it is a new "acute" infection or "chronic" hepatitis B.
- Anti-HBs or HBsAb (Hepatitis B surface antibody): A positive result indicates a person is protected against the hepatitis B virus. This can be due to receiving the hepatitis B vaccine or successfully recovering from a past hepatitis B infection.
- Anti-HBc or HBcAb total (Hepatitis B core antibody): A positive result indicates a person has been exposed to the hepatitis B virus at some point. However, a positive result alone does not indicate whether the person has a past or current infection. It must be interpreted alongside the results of the first two tests.
The presence of the HBsAg antigen indicates that a person is infectious. The body normally produces antibodies to HBsAg as part of the immune response to infection. This antigen is also used to make the HepB vaccine. The presence of anti-HBs is generally interpreted as indicating recovery and immunity from HBV infection. It also develops in a person successfully vaccinated against hepatitis B. Anti-HBc appears at the onset of symptoms in acute hepatitis B and persists for life. The presence of total anti-HBc indicates previous or ongoing infection with HBV, but the timeframe is undefined. People with immunity from a vaccine do not develop anti-HBc. IgM anti-HBc positivity indicates a recent infection within less than six months. Its presence indicates acute infection.
It is important to note that testing should not be a barrier to vaccination, especially for populations with limited access to healthcare. Vaccination should not be deferred when the manufacturer of previously administered doses is unknown or unavailable.
Indian Doctors Sue Bill Gates Over Vaccine Safety
You may want to see also
Explore related products
Vaccine safety and efficacy
The hepatitis B vaccine is considered safe and effective for all newborns, children up to 18 years of age, and adults, especially those at high risk of infection. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend the hepatitis B vaccine for all newborns, infants, children, adolescents, and adults.
The hepatitis B vaccine is a safe and effective way to prevent hepatitis B infection, a liver disease caused by the hepatitis B virus (HBV). It is also known as the first "anti-cancer" vaccine because it prevents hepatitis B, the leading cause of liver cancer worldwide. The vaccine has been shown to provide long-term protection against illness from acute and chronic hepatitis B infection, hepatitis delta, and lowers the lifetime risk of liver cancer.
The hepatitis B vaccine is generally given as an injection in the arm and is available in two-dose or three-dose series. The three-dose series is given on a 0, 1, and 6-month schedule, while the two-dose series is administered about a month apart. The two-dose vaccine does not require a booster dose for long-term protection. It is important to complete the vaccine series, preferably beginning at birth, to ensure maximum protection.
The most common side effects of the hepatitis B vaccine include soreness, redness, and swelling at the injection site. Other possible side effects include injection site pain, headache, and fatigue, which are usually mild and last 1-2 days. It is important to note that you cannot get hepatitis B from the vaccine, as all hepatitis B vaccines used since 1986 are made synthetically and do not contain any blood products.
Numerous studies have been conducted by the World Health Organization, the Centers for Disease Control and Prevention, and various medical societies to assess the safety and efficacy of the hepatitis B vaccine. These studies have found no evidence linking the vaccine to sudden infant death syndrome (SIDS), autism, multiple sclerosis, or other neurological disorders. The CDC takes concerns about vaccines and immune system diseases seriously and continues to conduct research to examine the effects of vaccines on the immune system.
Vaccinations and Peanut Allergies: Is There a Link?
You may want to see also
Frequently asked questions
The Hepatitis B vaccine is generally given as a three-dose series, but there are two-dose and four-dose vaccines available.
The World Health Organization (WHO) recommends a 0, 1, and 6-month schedule. The first shot can be given at any time, but newborns should receive it in the delivery room. The second shot is administered at least one month after the first, and the third shot is administered at least four months after the first and two months after the second.
Yes, alternative schedules may be considered. For instance, the Engerix-B vaccine can be given on an accelerated, four-dose schedule, with three shots administered within two months and a booster dose at one year.
The Hepatitis B vaccine is recommended for all newborns, children up to 18 years of age, and adults, especially those at higher risk of infection.
![International Certificate of Vaccination with Vinyl Document Holder - World Health Organization Bilingual Version [cards] World Health Organization [Jan 01, 2007]](https://m.media-amazon.com/images/I/61SHjBP1VYL._AC_UL320_.jpg)
